Norma Biln
Founder chez Augurex Life Sciences Corp.
Profil
Norma K.
Biln is the founder.
She founded Augurex Life Sciences Corp.
in 2006 and currently holds the title of President, Chief Executive Officer & Director.
Ms. Biln is also currently a Director at BIOTECanada and New Ventures Bc.
In the past, she served as Chairman at BioTalent Canada from 2015 to 2017.
Ms. Biln also held positions as Director-Corporate Market Development at Nventa Biopharmaceuticals Corp.
from 2004 to 2005, Lead Independent Director at Resverlogix Corp., Director-Sales & Marketing at Stressgen Bioreagents Corp., and Principal at Abbott Laboratories, Amgen, Inc., and Pfizer Pharmaceuticals, Inc. Ms. Biln obtained her undergraduate degree from McGill University.
Postes actifs de Norma Biln
| Sociétés | Poste | Début |
|---|---|---|
Augurex Life Sciences Corp.
 Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada. | Founder | 28/04/2010 |
New Ventures Bc
 New Ventures Bc Miscellaneous Commercial ServicesCommercial Services New Ventures BC is a private company that provides education, tools, networking, and funding to help BC tech startups succeed. New Ventures Bc is currently hosting a weekly startup seminar series as part of the 2023 New Ventures BC competition presented by Innovate BC. The company is based in Vancouver, Canada. The Canadian company relies on the support of government, corporate, and volunteer mentors and jurors to offer their programs. | Director/Board Member | - |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Director/Board Member | - |
Anciens postes connus de Norma Biln
| Sociétés | Poste | Fin |
|---|---|---|
BioTalent Canada
 BioTalent Canada Miscellaneous Commercial ServicesCommercial Services BioTalent Canada is a non-profit organization, which focuses on building partnerships and skills for Canada?s bio-economy to ensure the industry has access to job-ready people. It connects employers with job seekers, delivers human resource information, and skills development tools so the biotech industry through projects, research and product development .The company is headquartered in Ottawa, Canada. | Chairman | 01/09/2017 |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Corporate Officer/Principal | 01/06/2005 |
| RESVERLOGIX CORP. | Director/Board Member | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Formation de Norma Biln
| McGill University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| AMGEN INC. | Health Technology |
| RESVERLOGIX CORP. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
Stressgen Bioreagents Corp.
 Stressgen Bioreagents Corp. Medical/Nursing ServicesHealth Services Stressgen Bioreagents Corp. was engaged in expansion of product development program in the core areas of Cell Signaling and Phosphorylation. Its products were active kinases, phosphor-specific antibodies and StressXpress® kinase activity kits. Its research areas were including new kits, antibodies and proteins for Heat Shock, Apoptosis, Oxidative Stress and novel molecular biology tools. Stressgen Bioreagents was headquartered in Victoria, CA. | Health Services |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Health Technology |
BioTalent Canada
BioTalent Canada Miscellaneous Commercial ServicesCommercial Services BioTalent Canada is a non-profit organization, which focuses on building partnerships and skills for Canada?s bio-economy to ensure the industry has access to job-ready people. It connects employers with job seekers, delivers human resource information, and skills development tools so the biotech industry through projects, research and product development .The company is headquartered in Ottawa, Canada. | Commercial Services |
New Ventures Bc
New Ventures Bc Miscellaneous Commercial ServicesCommercial Services New Ventures BC is a private company that provides education, tools, networking, and funding to help BC tech startups succeed. New Ventures Bc is currently hosting a weekly startup seminar series as part of the 2023 New Ventures BC competition presented by Innovate BC. The company is based in Vancouver, Canada. The Canadian company relies on the support of government, corporate, and volunteer mentors and jurors to offer their programs. | Commercial Services |
Augurex Life Sciences Corp.
Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada. | Health Technology |
